Cite

HARVARD Citation

    Mo, X. et al. (2019). HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers. Cell chemical biology. 26 (3), pp. 331-339.e3. [Online]. 
  
Back to record